Aging as a Biological Target for Prevention and Therapy
Authors:
- 2 October 2018
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 320 (13) , 1321-1322
Abstract
This Viewpoint discusses targeting fundamental biological aging processes through nutritional, genetic, and pharmacologic interventions to delay or prevent theKeywords
This publication has 8 references indexed in Scilit:
- Faculty Opinions recommendation of Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice.2018
- NIA Interventions Testing Program: Investigating Putative Aging Intervention Agents in a Genetically Heterogeneous Mouse ModelEBioMedicine, 2017
- Geroscience and the trans-NIH Geroscience Interest Group, GSIGGeroScience, 2017
- Transient rapamycin treatment can increase lifespan and healthspan in middle-aged miceeLife, 2016
- Metformin as a Tool to Target AgingCell Metabolism, 2016
- Dissecting the Mechanisms Underlying Unusually Successful Human Health Span and Life SpanCold Spring Harbor Perspectives in Medicine, 2015
- Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicityBMJ Open, 2015
- Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose ToleranceJAMA, 2003